Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Encephalopathy, Hepatic, Cerebrovascular Disorders or Liver Failure
and you are
over 18
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The cerebrovascular autoregulation (AR) is impaired in patients with hepatic encephalopathy. Patients with the indication to liver transplantation mostly have mild to severe hepatic encephalopathy. Transplantation should recover the encephalopathy. The aim of the study is to investigate the AR during liver transplantation, with the questions if the AR is impaired at the beginning of surgery and if there are changes in AR. For follow up the AR will be measured at the first days after transplantation at the ICU.

Provided treatments

  • Other: No interventions
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01597102. The sponsor of the trial is Johannes Gutenberg University Mainz and it is looking for 20 volunteers for the current phase.
Official trial title:
Cerebrovascular Autoregulation During and After Liver Transplantation